A recent study identifies multi-omics signatures associated with Alström and Bardet-Biedl syndromes through integrated oral microbiome and metabolome profiling. This research could pave the way for new diagnostic and therapeutic strategies for these rare diseases.
integrated oral microbiome and metabolome profiling identifies disease associated multi omics signatures in alstr m and bardet biedl syndromes
Original title: “Integrated Oral Microbiome and Metabolome Profiling Identifies Disease-Associated Multi-Omics Signatures in Alström and Bardet-Biedl Syndromes.”